Skip to main content
. Author manuscript; available in PMC: 2015 Jan 29.
Published in final edited form as: Gynecol Oncol. 2014 Jan 14;132(3):578–584. doi: 10.1016/j.ygyno.2014.01.007

Fig. 2.

Fig. 2

Kaplan–Meier estimates of hematologic, peritoneal, and lymphatic recurrences beyond the radiation field. A, Improved disease-free survival was observed with receipt of chemotherapy in stage IIIC, grade 1/2 endometrioid endometrial carcinoma (P = .02). B, Disease-free survival was unchanged after adjuvant chemotherapy in stage IIIC grade 3 endometrioid and type II endometrial carcinoma combined (P = .91).